Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the completion of the transaction, the chief executive officer now directly owns 71,589 shares in the company, valued at $32,782,750.77. This represents a 13.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Synopsys Stock Performance
Shares of Synopsys stock opened at $486.00 on Friday. The firm has a 50-day simple moving average of $456.95 and a two-hundred day simple moving average of $483.94. The company has a market cap of $75.41 billion, a P/E ratio of 33.47, a price-to-earnings-growth ratio of 3.23 and a beta of 1.11. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $624.80.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.40 by $0.27. Synopsys had a net margin of 36.12% and a return on equity of 20.48%. The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same quarter in the prior year, the firm earned $3.00 EPS. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. Equities research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.
Analysts Set New Price Targets
Get Our Latest Analysis on SNPS
Institutional Trading of Synopsys
Large investors have recently bought and sold shares of the business. Norges Bank purchased a new stake in shares of Synopsys in the 4th quarter valued at approximately $583,608,000. GAMMA Investing LLC grew its stake in shares of Synopsys by 54,286.0% in the 1st quarter. GAMMA Investing LLC now owns 1,196,492 shares of the semiconductor company’s stock valued at $513,116,000 after buying an additional 1,194,292 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of Synopsys by 21.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,902,696 shares of the semiconductor company’s stock valued at $2,864,933,000 after buying an additional 1,045,326 shares during the period. Nuveen LLC purchased a new stake in shares of Synopsys in the 1st quarter valued at approximately $341,480,000. Finally, Pictet Asset Management Holding SA boosted its position in shares of Synopsys by 38.3% during the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock worth $1,043,518,000 after purchasing an additional 673,837 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- Differences Between Momentum Investing and Long Term Investing
- A Large Oil Supply Draw Could Mean Upside in These 3 Energy Names
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks Getting Rare Double Upgrades From Analysts
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- This Banking Giant Just Got a $90 Price Target Upgrade
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.